I In unanaesthetized dogs, cholinomimetic drugs and their antagonists were injected into the inferior horn of the left lateral cerebral ventricle. Injection volumes of 5 1l were used to limit spread of the drugs beyond the inferior horn. The effects on EEG and behaviour were recorded and compared with the effects of the same doses given into the body of the right lateral ventricle a little behind the foramen of Monro.
Introduction
Methods Haranath & Shyamalakumari (1973) described sleep following tubocurarine injected into the lateral ventricle in small doses (500 ng) or perfused in low concentration (10 ng/min) through the cerebral ventricles. They postulated that the site for induction of sleep could be in the structures lining the inferior horn of the lateral cerebral ventricles. Earlier Haranath, Sunanda-bai & Venkatakrishna-Bhatt (1967) had injected cholinomimetic drugs like acetylcholine, physostigmine and neostigmine and their antagonists atropine, tubocuraine and hexamethonium into the carotid arteries of unanaesthetized dogs and observed sleep following both groups of drugs. The present study was designed to establish whether the site of action for sleep induced by the above groups of drugs could indeed be in the structures lining the inferior horn. The effects of noradrenaline and 5-hydroxytryptamine (5-HT) were also studied since they too are involved in sleep mechanisms (Jouvet, 1969) .
The studies were made on dogs of either sex (6.5-14 kg Another ventricular cannula, with shaft length 17 mm, was implanted on the opposite side into the body of the right lateral ventricle, a little behind the foramen of Monro (8 mm behind the coronal suture and 5 mm lateral to midline). This position will be referred to as the body of the lateral cerebral ventricle.
EEG
To record the EEG, silver wires were stitched to the skin bilaterally on the frontal, parietal and occipital regions of the head and were connected to an Encardio-Rite polygraph at the time of recording.
Observations
The dogs had recovered completely on the day after implantation of the cannulae and drugs were injected into the cerebral ventricles on the following days. A minute to minute record of the behaviour of the animal was kept. Closure of the eyes for more than 3 min in a sleeping posture with slow and deep respiration and a high voltage slow wave EEG (when recorded) was considered to be sleep. The time until the animal awoke was recorded as a continuous sleep period. Eye movements were seen and were often associated with movements of the muzzle and paws and were confirmed as rapid eye movement (REM) sleep by the EEG changes. The times when these movements occurred were noted in the record. At the effective (sleep-inducing) doses the drug was tried in three or four different dogs and sometimes in the same dog more than once. Only one drug was tried on each day. The animals were generally unrestrained during observations. The dose of a drug necessary to induce sleep was first established without the EEG leads attached to the polygraph. In subsequent experiments with this dose EEG was recorded and mild restraint was necessary at the beginning of the experiment. Soon after the injection the dogs became quiet and later went to sleep when no further restraint was necessary.
Sterilized solutions of drugs were injected into the inferior horn in a volume of 5 g1 to limit the spread of the drug only to a small area around the tip of the cannula in the inferior horn. occurred only in a few instances. In 10 gg doses it produced some salivation and lacrimation but no sleep; 1-2 ig doses had no effect. (+)-Tubocurarine injected into the inferior horn in doses as little as 10-20 ng produced sleep (Figure 2 ). There were movements of eyes, muzzle and paws during the sleep so produced. Figure 3 shows the EEG taken before and after injection of (+)-tubocurarine 10 ng into the inferior horn. In the record taken 30 min after injection of (+)-tubocurarine the dog was awake and showed increased neuronal activity and desynchronization. After 47 min, the dog was asleep and showed high voltage slow waves. In the 50th min the dog was still asleep but showed rapid eye movements and EEG desynchronization. The same doses of 10-20 ng tubocurarine did not produce any effect when given into the body of the lateral ventricle. The injection of 500 ng (+)-tubocurarine into the body of the lateral cerebral ventricle was required to produce sleep (Haranath & Shyamalakumari, 1973) . That the inferior horn is a site for induction of sleep was borne out not only with (+)-tubocurarine but by the cholinomimetic drugs like acetylcholine, physostigmine, pilocarpine and nicotine, and by the acetylcholine antagonists, atropine, hyoscine and hexamethonium. The above drugs induced sleep in small doses when injected into the inferior horn but the same doses were ineffective when injected into the body of the lateral ventricle.
Since both cholinomimetic drugs and their antagonists produce sleep, this common effect might be achieved through a depolarizing block by the cholinomimetics and a competitive block by the antagonists. The fact that the doses of cholinomimetic drugs required to produce sleep are much higher than those of their antagonists supports this view. This also would fit into the concept of increased activity of cholinergic mechanims in wakefulness and REM sleep. For example, Haranath & VenkatakrishnaBhatt (1973) reported diminished release of acetylcholine into the perfused cerebral ventricles in unanaesthetized dogs just before and during sleep, and an increased release during REM sleep. Similarly Celesia & Jasper (1966) observed in cats diminished release of acetylcholine from the physostigminetreated cerebral cortex during natural and barbiturateinduced sleep. Jasper & Tessier (1971) and GadeaCiria, Stadler, Lloyd & Bartholini (1973) have also reported diminished release of acetylcholine during slow wave sleep and an increase during REM sleep.
The inferior horn appears to be a site for induction of sleep by other mechanisms also, since noradrenaline induced sleep in much smaller doses when injected into the inferior horn than when given into the body of the lateral ventricle. The results with 5-HT were equivocal since it produced sleep only at a dose of 0.5 jg but not higher or lower doses. Even at that dose, sleep occurred only after 45 minutes.
The important structures lining the inferior horn are the amygdala and the hippocampus. Although it is unlikely that a single neurohumoral mechanism can be solely responsible for induction of sleep at all levels (King, 1971) , it is likely that cholinergic mechanisms are involved in some pathway situated in the limbic system (Hernandez-Peon, Chavez-Ibarra, Morgane & Timo-laria, 1963) and particularly in the hippocampal region (Kim, Choi, Kim, Kim, Kim, Park & Ahn, 1975 ).
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